Dr. David Manheim

David Manheim is a public policy researcher currently visiting the Technion, specializing in biological and technological risks and the impacts of new technologies, as well as a lead researcher at 1Day Sooner, an advocacy organization for Human Challenge Trial volunteers. He has done research on topics from COVID-19 to the future of pandemic response and monitoring to forecasting risks of AI at the World Bank, the Council on Strategic Risks, and Oxford’s Future of Humanity Institute. In addition to dozens of academic publications in journals ranging from Technological Forecasting and Social Change to Clinical Infectious Diseases, and from Health Security to PLoS Computational Biology, his work on the implications, risks, and management of novel technologies has appeared in Foreign Affairs and TechCrunch.